Hello Everyone, Let me say thanks in advance for any and all advice or comments. It is very kind of you to share your stories and opinions. I may not be able to respond right away. Sorry for such a long post. I just want to get all of my info and questions out there. I will update with new information as I get it.
My husband and I are looking for advice about what is most likely the beginning of my Ovarian Cancer journey. I have not had a biopsy yet but all signs indicate OC.
I am a 62 years old woman who most likely has ovarian cancer. I went to my primary care physician for what I thought were gastrointestinal issues. Occasional abdominal pain. A CT scan and MRI show masses in both ovaries with spread to some surrounding areas as shown in the report below.
I have seen one gynecologic oncologist with Texas Oncology so far in Dallas Texas near where I live. It turns out my ACA Cigna Connect individual health insurance is not very good because he referred me to a colleague who seems to be the only Texas Oncology who has "block time" to perform operations in a Methodist Health Care hospital (Charlton Cancer Center) which also seems to be practically the only hospital my insurance covers.
I am scheduled for a full body CT scan with contrast Monday, Nov. 27, 2023. I am scheduled to my first consultation with the new gynecologic oncologist Nov. 28, 2023. I am scheduled for hospital pre-admission testing Dec. 1, 2023.
I am scheduled for an operation Dec. 7, 2023. They said they will do laparoscopic inspection and based on that may open up the abdomen to do the debulking or may opt for chemotherapy first and later do the debulking. He also discussed possible intestinal surgery and colostomy reversal. I am a little confused about when the biopsy would be done and will ask about that on the next visit. I guess this is part of what is called "staging"?
One thing I wish I had done sooner but will do this coming Monday is schedule a visit to MD Anderson Cancer Center in Houston. It will be self pay there but my husband and I agree that we likely have enough money to pay for it. I am guessing about $100,000. Has anyone here done that?
What questions should I be asking the doctors at this time?
Would it be worth waiting for a MD Anderson doctor if they could not do it sooner than the Texas Oncology / Charlton Cancer Center Dec. 7, 2023 operation?
I hope it is not inappropriate to post my CT scan results here. Please see below.
EXAM: MRI Pelvis W / WO (72197)
HISTORY: Right ovarian mass on recent CT suspicious for neoplasm, presents for further assessment.
TECHNIQUE: Multiplanar, multisequence MR images of the pelvis were obtained before and after the intravenous administration of 15 mL Clariscan.
COMPARISON: CT abdomen and pelvis dated 10/26/2023.
FINDINGS:A complex right ovarian cystic mass measures 4.8 cm AP by 4.0 cm CC by 4.4 cm TRV and demonstrates lobulated enhancing mural nodularity, highly suspicious for a cystic ovarian neoplasm. The left ovary measures 3.0 x 2.9 x 2.7 cm and demonstrates multiple small cysts, the largest measuring 1.8 cm. There is a poorly defined area of enhancing soft tissue within the left adnexal region, which partially encases the left ovary, extends over the anterosuperior aspect of the uterus, and demonstrates partial effusion restriction, suspicious for peritoneal metastases (postcontrast series 1201 images 45-50). There is a similar-appearing confluent masslike soft tissue within the anterior aspect of the left lower quadrant, which measures 6.0 x 2.9 cm in axial diameter on series 201 image 11). This finding was present retrospect on prior CT abdomen and pelvis dated 10/26/2023 and is highly suspicious for lower omental/mesenteric metastases. The uterus measures 5.5 x 2.9 x 4.3 cm. Endometrial stripe measures 3 mm in thickness. No definite fibroids are identified. The cervix and vagina are unremarkable. Osseous structures are unremarkable. Normal muscle bulk about the pelvis.
IMPRESSION:
1. 4.8 x 4.0 x 4.4 cm complex right ovarian cystic mass, highly suspicious for a neoplasm.
2. Ill-defined area of enhancing soft tissue within the left adnexal region, which partially encases the left ovary and extends over the anterosuperior aspect of the uterus, highly suspicious for peritoneal metastases. There is similar-appearing masslike soft tissue within the anterior left lower quadrant, which was present and retrospect on prior CT and is highly suspicious for lower omental/mesenteric metastases. Dedicated CT of the abdomen and pelvis with intravenous contrast would be helpful for more complete assessment. Gynecologic-oncologic consultation recommended.
Report Ends